As a result of completing this activity, the participant will be able to Explain the basic physiology and pharmacology of relevance to conducting anesthesia for craniotomy Describe factors unique to craniotomy in the preoperative evaluation, choice of monitors, anesthetic induction, maintenance, and emergence Describe special considerations for posterior fossa procedures and emergency craniotomy Author Disclosure Information:
A nesthesia for craniotomy presents special challenges. The brain is enclosed in a rigid skull and most craniotomies are performed for the treatment of space-occupying lesions. The brain is poorly tolerant to interruption of substrate delivery. It also is highly vascular with the potential for massive perioperative hemorrhage. Unlike most other organs, regions of the brain have specialized function, posing limitations to surgical intervention.
Interactions between anesthesia and surgical operating conditions can be expected. Anesthetics and physiological factors controlled by the anesthesiologist have clinically important effects on brain bulk, blood flow, metabolism, vascular autoregulation, evoked potential responses, and epileptogenicity. Specific anesthetics can complicate the differential diagnosis of failure to emerge from anesthesia and the detection of new neurological deficits. At the same time, no definitive evidence has associated anesthetic drugs or techniques with either worsened or improved functional or survival outcomes in patients undergoing craniotomy. Practice has been derived largely from human studies performed with insufficient statistical power to provide definitive answers, implications of animal research, and studies made in other patient populations. Appreciating these limitations, this article presents a practical review of the anesthetic management of patients with intracranial pathology requiring surgery.
No definitive evidence has associated anesthetic drugs or techniques with either worsened or improved functional or survival outcomes in humans undergoing craniotomy. participate in defining the cause. Thus, a brief preoperative neurological examination is useful.
It is also important to gain insight into the magnitude of intracranial hypertension and possible interactions with anesthetic agents. Acute changes in intracranial pressure (ICP) (e.g., epidural hematoma, acute subdural hematoma, or postoperative hematoma) are likely to be more sensitive to anesthetic effects on brain volume because the brain has had less time to compensate for the expanding mass than would be the case with slow-growing tumors. The anesthesiologist also will need to appreciate the characteristics of the lesion with respect to potential for major hemorrhage (e.g., vascular vs. avascular meningioma, tumors in close proximity to the circle of Willis, sagittal sinus, or cavernous sinus, etc.).
For aneurysms, it is valuable to know the interval since aneurysmal hemorrhage with respect to urgency for surgery relative to the risk of vasospasm. Most surgeons prefer early intervention to avoid rebleeding. 1 Patients receiving nimodipine or nicardipine may exhibit exaggerated hemodynamic responses to volatile anesthetics.
For arteriovenous malformations, a history of preoperative neuroradiological intervention can assist the anesthesiologist in anticipating the magnitude of blood loss and potential for perioperative malignant brain swelling. Resection of a radiologically obliterated arteriovenous malformation typically poses little risk for these complications, whereas previously untreated lesions raise concern. The size, location, and morphology of the arteriovenous malformations are likely to be relevant as well.
MONITORING
Basic monitors for craniotomy include standard ASA monitors and an intraarterial catheter. The arterial catheter is valuable in providing strict control of blood pressure (particularly during emergence). Central venous pressure (CVP) monitoring is usually not required for management of tumors unless the case is expected to be exceedingly long or if major hemorrhage is anticipated (e.g., nonembolized vascular meningioma, tumor encasement of major vessels). It may be worthwhile to consult with the neurosurgeon regarding the potential for blood loss and balance that risk against the patient's general medical status and the risk of CVP catheter placement.
One exception to this rule is intracranial aneurysm surgery. CVP monitors are useful in these procedures. The brain receives approximately 20% of cardiac output when the body is at rest. If cardiac output is approximately 5 L/ min, it is easy to appreciate that uncontrolled aneurysmal hemorrhage can result in rapid exsanguination. Use of mannitol invalidates urine output as a monitor of intravascular volume status. The CVP catheter, particularly in patients with marginal cardiopulmonary status, will guide resuscitation and prevent overhydration. Another reason to place a CVP catheter is for delivery of vasoactive medications. It can be difficult to predict whether the surgeon will ask for blood pressure to be increased (e.g., during temporary vascular occlusion of the parent vessel) or decreased (e.g., to facilitate clipping or reduce the rate of hemorrhage). Delivery of drugs into the central circulation provides the fastest onset of action and shortens the feedback loop for dose titration, facilitating exquisite control of blood pressure.
When a CVP catheter is not indicated, large-bore intravenous catheters will be sufficient for most patients. One drug to be careful with is mannitol. Extravasation from a peripheral intravenous catheter can lead to a compartment syndrome, potentially requiring fasciotomy. 2 Frequent monitoring of the quality of the intravenous site during mannitol infusion will help prevent this complication.
The jury is still out on whether intraoperative electrophysiological monitoring is useful to detect brain ischemia during craniotomy. 3, 4 Although evoked potential monitoring is sometimes advocated, concern remains regarding inappropriate responses to false-positive or false-negative readings. The added cost and inconvenience also detract from its widespread use. When electrophysiological monitoring is used, the key point for the anesthesiologist is to ensure that adequate signals can be obtained; this typically requires consultation with the technician. Because anesthetics (particularly volatile agents) dampen both motor and somatosensory evoked potentials, abrupt changes in delivered concentration (or high concentrations) should be avoided; if such a change in concentration becomes necessary, it should be communicated so that alterations in the evoked response are not attributed to surgical events. Some advocate electroencephalographic (EEG) monitoring to guide pharmacological neuroprotection; however, this practice remains controversial with little evidence of efficacy. If used, raw BIS waveforms are sufficient, as this provides a rough but sufficient estimate of EEG activity and is readily available. 5 Cranial nerve monitoring is often used during posterior fossa procedures. Implications for anesthesia largely pertain to the use of muscle relaxants. Although there is no contraindication to the use of relaxants during induction and positioning, it is important to ensure recovery of neuromuscular function before surgical stimulation of the cranial nerves located in the vicinity of the lesion. A valuable practice is to inform the surgeon and document twitch recovery on the anesthesia record.
Surgery for excision of epileptic foci often requires intraoperative EEG mapping, and sometimes an awake patient. It is important to appreciate the anticonvulsant effects of the different anesthetics. Most intravenous and volatile anesthetics suppress EEG activity and may degrade mapping. Conversion to a nitrous oxide-opioid technique or simply temporarily lightening the depth of anesthesia before mapping is commonly practiced. Propofol and dexmedetomidine have been found to be satisfactory adjuncts to opioids. 6 Conversely, small doses of proepileptic agents (e.g., methohexital) are occasionally requested to aid in identification of the focus. 7 Transcranial Doppler monitoring may be of value preoperatively in screening for cerebral vasospasm. 8 Transcranial Doppler monitoring during craniotomy is cumbersome and unsubstantiated as a modifier of outcome. There is hope that noninvasive ICP monitors, including transcranial Doppler waveform analysis and optic sheath diameter, will provide useful ICP data in the perioperative period. 9, 10 
ANESTHESIA INDUCTION
Concerns unique to anesthesia induction for craniotomy are principally related to ICP in the case of mass lesions, prevention of hemorrhage in the case of vascular lesions, and consideration of the complex surgical positions often used. Modern study of anesthetic effects on ICP began in the late 1960s when ICP measurements were made in patients anesthetized for tumor surgery. 11 Major ICP increases were often observed at induction of anesthesia. In the zeal to provide optimal care, it was thought that any increase in ICP could only be harmful to the patient and the use of anesthetics known to increase ICP was widely discouraged. Although logical, this admonition came at a cost. Something must be used to provide anesthesia, and drugs known to decrease ICP (e.g., propofol) typically have a prolonged duration of action when used in isolation. In fact, data relevant to the effects of modern anesthetics on ICP in human subjects are limited; most information has been derived from animal studies. More importantly, there are little data regarding any relationship between anesthetic effects on ICP and outcome from craniotomy. The few human studies that have been performed used crude outcome metrics, preventing definition of the relevance of this problem. 12 As a result, the use of various anesthetics during neurosurgery has been broadened so as to allow all facets of a successful anesthetic to be considered when selecting drugs. We cannot measure ICP in every patient. Consequently, we rely on information derived from limited human data and extrapolate information from animal studies. This seems to work. Case reports in the literature showing a causal relationship between anesthetics and brain herniation on induction in patients with known intracranial lesions are essentially nonexistent. The one exception is patients with an occult lesion undergoing nonneurosurgical procedures, where vigilance for control of arterial carbon dioxide and head position may be less likely. The vast majority of patients anesthetized for craniotomy emerge from anesthesia with their neurological status unchanged or with alterations directly attributable to the site of surgery. As a result, it is difficult to advocate any specific anesthetic or technique for the purpose of induction or maintenance. In human beings, we know that the effects of volatile anesthetics on ICP can be blunted by simultaneous moderate hyperventilation. 13 We also know that higher concentrations of volatile anesthetics and nitrous oxide perturb cerebral autoregulation, and this could influence decisions regarding blood pressure management. 14 We also know that there are numerous methods to blunt hemodynamic responses to endotracheal intubation and application of the pin head-holder. Cumulatively, these concerns must be weighed when selecting agents for induction of anesthesia for craniotomy.
With respect to cerebral aneurysms, ICP is of less concern than is prevention of abrupt and major increases in mean arterial pressure (MAP) that may promote rupture of the aneurysm. The mortality rate associated with divide at: aneu-rysm rupture during induction is substantial. The goal is avoidance of hypertension. If an error is to be made, it should be toward hypotension. Some advocate purposeful reduction of MAP during induction with systemic vasodilating agents or intense analgesia to insure against hypertensive responses to intubation. This is usually unnecessary. Instead, controlled and progressive increases in depth of anesthesia sufficient to blunt responses to intubation are sufficient to prevent hemorrhage. This is a setting where a slow, careful induction sequence is warranted.
One feature unique to craniotomy (and posterior cervical spine surgery) is use of the pin head-holder. Its application in a lightly anesthetized patient is likely to cause major hemodynamic responses. There have been innumerable studies to define the best method to prevent increases in blood pressure and heart rate. Numerous drugs are effective, and most have been selected to deepen anesthesia. One method that works reliably for this author is intravenous administration of 50 to 100 mg remifentanil, which is allowed to take effect within 1 to 2 minutes before the head-holder is applied.
Neurosurgery rarely uses a convenient supine surgical position. There is substantial head motion during positioning and placement of the dressing. Intraoperatively, airway access is limited once positioning and draping are completed. Accidental extubation can be disastrous, not only due to lack of ventilation, but also because of likely contamination of the sterile field to reestablish the airway. Hence, meticulous taping of the endotracheal tube is a routine element of anesthetic induction. Care should be made at emergence to prevent damage to skin when layers of tape and adhesives are removed.
ANESTHESIA MAINTENANCE
Maintenance of anesthesia during craniotomy is usually uncomplicated and generic. There are two special considerations. In patients with intracranial mass lesions, brain bulk can be a problem, particularly when the dura is being opened. A swollen (tight) brain can herniate through the dural defect, complicating further dural incision. In this circumstance the anesthesiologist is frequently requested to ''relax'' the brain. There are multiple methods by which this can be achieved (Table 2) . Usually, several changes are made simultaneously that cumulatively result in improved operating conditions. The anesthesiologist can often prevent this problem during patient positioning by assuring the head is sufficiently elevated above the heart, 15 which promotes venous drainage. Additional intraoperative head elevation can often produce dramatic and rapid reduction in brain bulk. This must be weighed against the risk of air embolism, in which case precordial Doppler monitoring might be considered. Doppler monitoring usually is not essential, although vigilance for abrupt decreases in end-tidal CO 2 is recommended. Placement of the head 101 to 151 above the heart is usually sufficient to promote cerebral venous drainage without risk of air embolism or hemodynamic compromise.
Reduction in brain bulk can also be achieved by discontinuing inhalation anesthetics that are known vasodilators. The first drug to discontinue is nitrous oxide. It is rapidly eliminated and a greater vasodilator than isoflurane (because nitrous oxide, unlike potent agents, does not have compensatory reduction in metabolic rate causing coupled reduction in cerebral bold flow [CBF]). 16 Temporary discontinuation of the volatile anesthetic may also be of benefit.
Placement of the head 101 1 to 151 1 above the heart is usually sufficient to promote cerebral venous drainage without risk of air embolism or hemodynamic compromise.
There is evidence that opioids can increase ICP. The elevation is modest and transient. Human study has provided convincing evidence that opioids increase ICP as a result of MAP reduction. When autoregulation is intact, decreased MAP causes cerebral vasodilation and a concordant increase in cerebral blood volume (CBV) and ICP. Opioid-induced ICP increases can be avoided simply by controlling MAP during opioid administration. 17 When MAP is controlled, opioids are unlikely to be an issue during maintenance with respect to brain bulk. Particularly in the case of remifentanil, an increased opioid dose can be used to offset a reduced volatile anesthetic dose to manage brain bulk without concerns of accumulation. Mannitol decreases brain bulk by creating a hyperosmotic state in the intravascular compartment. Mannitol does not cross the intact blood-brain barrier. Thus, an osmotic gradient is formed across the blood-brain barrier causing water to flux from the extravascular to the intravascular compartment. Mannitol also improves deformability of red blood cells, thereby decreasing viscosity and promoting increased blood flow. As a consequence, autoregulation causes vasoconstriction to maintain constant flow, which may result in decreased CBV. Hypertonic saline shares the same properties. Mannitol is best given around the time of skin incision (typically 0.5 to 1.0 mg/ kg) so the peak effect becomes available when the dura is opened. Additional mannitol may be of value if the brain is still ''tight.'' It is critical to ensure unobstructed drainage of urine when these diuretics are employed.
Hyperventilation is discussed in the next section. The impact of hyperventilation on brain bulk is likely to be modest but can at least temporarily improve operating conditions. 18 Certainly, hypercapnia should be corrected. The response of the cerebral vasculature to changes in PaCO 2 is rapid. There has been a major shift in attitude regarding the value of hypocapnia with the preponderance of data indicating that major reduction in PaCO 2 increases the risk of secondary ischemic injury. 19 Temporarily stabilizing PaCO 2 in the range of 32 to 36 mmHg is usually adequate if mannitol is also used.
If the foregoing actions are not successful, some benefit may be obtained from administration of propofol. Large doses cause major reduction in metabolic rate and a coupled reduction in CBF. This can be effective but may prohibit adequate neurological evaluation upon emergence if high doses are sustained. Because this may commit the patient to postoperative intubation and ventilation, consultation should be made with the surgeon before taking this step.
Lumbar cerebrospinal fluid (CSF) drains are often placed for aneurysm clipping to decrease the retractor pressure required to expose the aneurysm at the base of the brain and for skull base surgery to improve the operative field. The volume drained often exceeds 100 mL, making this technique perhaps the most effective of all options in reducing brain bulk. CSF drainage is usually not carried out until after the dura is opened. Premature reduction in brain bulk can tear bridging veins draining into sinuses, causing an acute subdural hematoma. However, it is of value to ensure patency of the drain after final surgical positioning: observe progression of the air/fluid level through the connected catheter (less than 1 mL of CSF drainage is required to confirm this), and then leave the drain marked and closed until surgical requirements dictate that it be opened. To avoid transtentorial herniation, CSF drains are rarely used for supratentorial tumor surgery. Occasionally CSF drains are placed for transsphenoidal pituitary surgery, not to drain CSF, but to allow injection of saline or air to force the tumor toward the sphenoid sinus to facilitate surgical excision. Transport of patients with either a lumbar drain or ventriculostomy is most safely accomplished with a closed drainage system to prevent mishaps of unrecognized drainage or contamination.
MANAGEMENT OF VENTILATION
Alteration of PaCO 2 , within the range of approximately 20 to 80 mmHg, causes parallel changes in CBF (Supplemental Digital Content 1, http://links.lww.com/ASA/A262). CBF, in fact, is only a surrogate for CBV, the true determinant of ICP. CBF is easy to measure, while CBV is not (particularly in human subjects). It is logical, however, that given a constant MAP, PaCO 2 -induced changes in CBF should correlate with the cross-sectional diameter of the cerebral arterial vasculature. Decreased PaCO 2 results in decreased CBF and CBV. 20 There is also abundant clinical evidence that hyperventilation leads to a transient ICP reduction. Early neuroanesthesia practice, therefore, had been to cause large reductions in PaCO 2 . Data from head injury patients have brought about a major change in this perspective. Use of retrograde jugular venous hemoglobin-O 2 saturation measurement techniques has repeatedly shown that reduction in PaCO 2 can exacerbate cerebral hypoperfusion. 21 Moderate hyperventilation markedly increases the volume of ischemic tissue in patients with a traumatic brain injury (TBI). 19 This makes common sense: if the problem with intracranial hypertension is decreased blood flow, it does not seem logical to treat the disorder with vasoconstriction. As a result, it is difficult to advocate major reductions in PaCO 2 for patients undergoing craniotomy for space-occupying lesions. Modest reductions in PaCO 2 remain valuable, however, to counteract the vasodilating effects of volatile anesthetics. 22 Moderate hyperventilation markedly increases the volume of ischemic tissue in traumatic brain injury patients.
It is also important to recognize the value of calibrated end-tidal CO 2 monitoring during craniotomy. This measure decreases the need for repeated arterial blood gas sampling to control PaCO 2 , as PaCO 2 can be reliably calculated using the arterial/end-tidal CO 2 gradient and momentary end-tidal CO 2 . However, analysis in neurosurgical patients has shown that the arterial/end-tidal CO 2 gradient is not always predictable and should be measured for the individual patient when management of brain bulk is a concern. The gradient is generally stable unless the patient's position or hemodynamic values change substantially. Thus, definition of the gradient is best made once induction and positioning are complete (Supplemental Digital Content 2, http://links.lww.com/ASA/A263).
MUSCLE RELAXANTS
Several muscle relaxants have received special consideration in the context of craniotomy. The most interesting is succinylcholine. Evidence from both experimental animals and human subjects has shown that succinylcholine can increase ICP under conditions of intracranial hypertension. 23 When observed, the increase was transient. Other studies in TBI victims found no effect on ICP. 24 The mechanism for increase was originally thought to be attributable not to succinylcholine, but rather to preservatives used in its formulation. This argument has been disproved. In humans with brain tumors, ICP changes caused by succinylcholine can be blocked by preadministration of a defasciculating dose of nondepolarizing relaxants, 25 suggesting that fasciculations resulting from succinylcholine play a role in the ICP effects of the drug. Solid animal evidence supports this possibility. A probable mechanism is the massive fasciculation-induced afferent barrage from muscle spindles to the brain that causes transient increases in metabolic rate and coupled increases in CBF. 26 Common sense plays a major role in the decision whether to use succinylcholine in patients with intracranial hypertension. Pretreatment with a small dose of a nondepolarizing agent most likely makes the argument moot. At the same time, emergency airway management and the desire to minimize hypercapnia and hypoxemia in patients with TBI dictate that succinylcholine can be an appropriate adjunct for tracheal intubation until a relaxant with similar speed of onset and duration of action is introduced to clinical practice.
There is clear evidence that the duration of action of nondepolarizing muscle relaxants is decreased by a variety of anticonvulsant medications. 27, 28 Even short durations of exposure to anticonvulsants can elicit this effect. The mechanism remains unclear. Most patients requiring craniotomy are being treated with anticonvulsants. As a result, the nondepolarizing relaxant dosing regimen most likely will require alteration, and more frequent twitch monitoring will be important if sustained neuromuscular blockade is desired.
ANESTHESIA EMERGENCE
Planning for emergence from anesthesia for craniotomy begins with anesthetic induction. The goal of emergence is a predictable recovery to allow testing of neurological function in the context of controlled hemodynamics and airway patency. A unique concern is that failure to emerge may be attributable to either anesthesia or surgery. Management of failure to emerge depends on the cause. If it is attributable to surgery, either immediate exploration or a brain scan is usually performed to rule out hematoma formation. In contrast, if the problem is anesthesia based, patience in allowing elimination of anesthetic agents (monitoring end-tidal inhaled anesthetics, confirming the reversal of neuromuscular blockade, use of opioid antagonists) is the solution and the surgeon should be counseled that anesthesia is a likely explanation. Therefore, when planning the anesthetic, it is helpful to restrict use of maintenance agents to those that can be monitored for concentration or are amenable to pharmacological reversal. As an example, induction doses of propofol are unlikely to relate to failure to emerge from a 3-to 4-hour procedure. In contrast, higher blood propofol concentrations, sufficient to prevent awakening after a prolonged infusion, may be difficult to diagnose. If possible, it seems best to keep the anesthetic simple so that each compound can be independently ruled out as a cause for failure to emerge. In some cases (e.g., motor evoked potential mapping, history of severe postoperative nausea and vomiting [PONV]), benefit from continuous propofol infusion could outweigh these concerns.
Planning for emergence from anesthesia for craniotomy begins with anesthetic induction.
Emergence from anesthesia for craniotomy presents other management concerns. One of the strongest stimuli occurring during the procedure in intubated patients is application of the head dressing, which causes erratic motion of the endotracheal tube. This combined with lightening of anesthesia for the anticipated emergence can result in loss of hemodynamic control and difficulty in airway management, particularly if neuromuscular blockade is insufficiently reversed to allow extubation. A practical way to approach this situation is to assume that the anesthesiologist has 5 to 10 minutes after completion of the head dressing to allow a controlled emergence. If neuromuscular blockade was used, it can be maintained until completion of the head dressing; if volatile anesthetics were used, elimination of high concentrations can be initiated at the time of bone flap replacement. Anesthesia is augmented by either residual concentration of opioid (i.e., fentanyl or sufentanil) or continued remifentanil infusion. Rapidly cleared intravenous agents such as a lidocaine bolus can be of value in sustaining anesthesia for a few additional minutes. Supplementation with nitrous oxide during closure provides an advantage over intravenous agents because its concentration can be determined by endtidal concentration analysis, which aids in defining failure to emerge. Although nitrous oxide presents the potential to expand pneumocephalus, direct study has shown that this is not an issue during craniotomy closure. 29 Remifentanil may abrogate the need for nitrous oxide as it allows a balanced anesthetic with substantially reduced volatile anesthetic requirements, providing more rapid elimination. If remifentanil is used, the rate of infusion can remain unchanged from maintenance rates until the dressing is complete. This supports anesthesia during placement of the dressing but still allows a prompt and reliable emergence. 30 It is important, however, to provide transitional analgesia before discontinuation of remifentanil. Administration of 0.4 to 1.0 mg hydromorphone (or similar morphine dose) or 100 to 150 mg fentanyl (in adults) is usually sufficient to provide analgesia without altering predictability of emergence. Intravenous acetaminophen during wound closure, while unproven in craniotomy patients, may beneficially contribute to a multimodal pain management regimen.
A major concern in the postoperative interval is intracranial hemorrhage. 31 Reported frequency varies, but typically 1 to 1.5% of craniotomies will require reoperation for evacuation of hematoma. The cause is likely multifactorial. For reasons not yet understood, patients undergoing craniotomy often exhibit hypertension during emergence that is sustained through the early phases of recovery. Because of the implications of intracranial hemorrhage, it is imperative to plan for treatment of emergence hypertension before it becomes manifest. Prophylactic doses of labetalol/hydralazine are helpful. Others prefer a nicardipine infusion, which offers the advantage of continued blood pressure management during transport and admission to the postanesthesia care or intensive care unit. Emergence hypertension has not been proven to contribute to hematoma formation, but it has been shown that patients who develop postoperative hematomas are more likely to have had episodes of hypertension during emergence or early recovery. 32 The source of hemorrhage is typically within the surgical field (although hematoma may also be remote), and thus quality of hemostasis undoubtedly is critical. Because morbidity associated with postoperative hematoma formation requiring emergent evacuation is high, it seems prudent to diligently attend to hemodynamic management during emergence and early recovery.
PONV is frequent after craniotomy. Several studies have shown that more than 50% of patients suffer this complication. The incidence of PONV seems to be independent of whether the craniotomy was performed awake or under anesthesia, and independent of opioid dose. This suggests that brain surgery itself is contributory. Female patients, younger patients, and those undergoing infratentorial craniotomy are at greater risk. PONV is not just an early emergence problem, but can be sustained for hours or days after surgery. Ample evidence is now available that prophylactic antiemetic therapy markedly decreases the frequency and magnitude of the problem. 33 A single antiemetic dose just before emergence is likely to be tran-siently beneficial. However, repeated dosing will be required for sustained PONV suppression.
POSTERIOR FOSSA CONSIDERATIONS
Because of the primacy of the brainstem in maintaining vital function, posterior fossa procedures present special concerns. These are principally derived from three factors.
First, the volume of the infratentorial compartment is small. Thus, smaller hematoma volumes may be sufficient to compromise critical neural function. Further, brainstem edema developing after the conclusion of surgery may insidiously impair respiratory drive. It is appropriate to consult with the surgeon before planning extubation. Sufficient brainstem manipulation may warrant overnight endotracheal intubation. If so, emergence from anesthesia can be performed in the operating room to allow definition of postoperative baseline motor function before giving the sedation required for the patient to tolerate postoperative intubation.
Second, retraction on the brainstem can cause ischemia and permanent loss of function of nuclei that regulate hemodynamics and ventilation. In earlier days of neurosurgery, infratentorial procedures were often performed with spontaneous ventilation to continuously monitor function of respiratory drive centers. This practice has largely been abandoned in favor of mechanical ventilation, allowing control of brain bulk. A surrogate marker is heart rate, governed by nuclei in close anatomical proximity to the ventilatory drive nuclei. Precipitous decreases in heart rate are considered to be a signal of brainstem ischemia. The surgeon should be promptly notified. Most often, this situation spontaneously resolves with repositioning of the brain retractor. Atropine is rarely required for resuscitation but should be available. At the same time, atropine use may void subsequent reliance on heart rate as a surrogate monitor for brainstem ischemia.
Third, cranial nerve function may be compromised. The ninth and tenth nerves regulate gag reflex and laryngeal function. Injury may result in inability of the patient to protect against aspiration. Consultation with the surgeon is helpful in defining the potential for cranial nerve dysfunction. It is appropriate to plan emergence such that integrity of the gag/cough reflex can be tested before extubation. Absence of either reflex provides sufficient reason for continued intubation to prevent aspiration. Major sedation is usually unnecessary simply because the patient does not perceive the stimulation normally caused by the tube.
Posterior fossa procedures also present special concerns for airway management. Typically, the neck is flexed to optimize surgical exposure. This markedly compromises intraoperative access to the airway. Standard endotracheal tubes carry the risk of intraoperative kinking, which can present as a true and difficult to manage airway emergency (Figure 1 ). To avoid this, wire-reinforced tubes are typically used. When using a wire-reinforced tube, a soft bite block is necessary to prevent the patient from biting the tube and causing permanent occlusion. For the same reason, wire-reinforced tubes are typically changed to a standard tube at the conclusion of surgery should postoperative intubation be required.
TEMPERATURE MANAGEMENT
There has been enthusiasm for routine use of intraoperative hypothermia in patients requiring brain surgery, based on overwhelming laboratory evidence that reduction of brain temperature by even 21 to 31C produces major degrees of neuroprotection. Efficacy of mild to moderate hypothermia in human beings seems to depend upon the type of insult. An appropriately powered trial in patients with TBI failed to detect benefit, and in fact identified worsened outcomes in the elderly. 34 Recent follow-on research confirmed lack of efficacy in TBI 35 (Supplemental Digital Content 3, http://links.lww.com/ASA/A264). Despite considerable effort, there remains no clear evidence that induced hypothermia is neuroprotective in cardiac surgical patients. 36 The Intraoperative Hypothermia Aneurysm Surgery Trial (IHAST) studied 1,001 patients randomized to normothermia (36.01 to 37.01C) or hypothermia (32.51 to 33.51C) during intracranial aneurysm surgery. The primary dependent variable was Glasgow Outcome Scale score at 3 months postoperatively and no benefit of intraoperative hypothermia was observed. 37 This was a carefully controlled trial and thus argues effectively that induced hypothermia for routine cerebral aneurysm surgery is not helpful. These apparent failures to demonstrate hypothermia efficacy are balanced by positive trials in adults who remained comatose after resuscitation from out-of-hospital ventricular fibrillation-induced cardiac arrest. 38, 39 Cooling such patients for 12 to 24 hours is now widely recommended and may also be considered for other causes of cardiac arrest (e.g., loss of airway in which there is restoration of spontaneous circulation with the patient remaining comatose after drug-induced coma has been ruled out) 40 (Supplemental Digital Content 4, http:// links.lww.com/ASA/A265).
It is widely agreed that hyperthermia should be avoided in brain injury patients. Not only is there absence of theoretical benefit, there is substantial evidence in human beings that hyperthermia increases brain damage. 41 Hyperthermia is a frequent sequel to brain injury. 42 Patients suffering from subarachnoid hemorrhage, TBI, or cardiac arrest are likely to have multiple spontaneous episodes of hyperthermia during acute convalescence. Vigilance and prompt treatment of hyperthermia are recommended.
It is widely agreed that hyperthermia should be avoided in brain injury patients.
GLUCOSE MANAGEMENT
In the 1980s, it was recognized that ischemic brain poorly tolerates glucose loads. This is contrary to expectations because ischemia is defined as insufficient substrate delivery to maintain tissue viability. However, in the presence of insufficient oxygen, glucose is metabolized anaerobically, promoting tissue acidosis and free radical formation. Both animal and human evidence is highly consistent in associating a worsened outcome from discrete cerebral and spinal cord events when they occur in the context of hyperglycemia, 43 resulting in the widely accepted practice of withholding intravenous dextrose in patients at risk for central nervous system ischemia. Substantial evidence also supports this practice in the case of acute trauma to the The problem was recognized due to high-pressure alarms on the anesthesia machine. Because of the magnitude of neck flexion, manual exploration of the oral cavity was impossible. The lower image (B) was taken after the neurosurgeon broke scrub and repositioned the head-holder. While the repositioning was effective in correcting airway occlusion, the risk of wound infection was increased. This complication can be avoided by routine use of a wirereinforced endotracheal tube for posterior fossa procedures. When using this tube, a soft bite block should be inserted to prevent the patient's teeth from irreversibly crimping the tube.
central nervous system. However, recent human studies in neurosurgical patients (both intraoperative and postoperative) have shown that aggressive glucose management may exacerbate brain injury from hypoglycemic episodes. 44, 45 The threshold for treatment of perioperative hyperglycemia is thus arbitrary. Circumstantial evidence suggests a logical basis for treating values 4180 mg/dL (10 mmol/L).
PHARMACOLOGICAL NEUROPROTECTION
A holy grail of neuroanesthesia research has been defining the neuroprotective efficacy of anesthetics and other compounds. The simple interpretation of five decades of research is that we still lack definitive proof in human beings that pharmacological neuroprotection is a reality. Because most anesthetics reduce brain metabolic requirements, it makes sense that anesthetics will increase tolerance to ischemia in the context of diminished substrate supply. However, the response of the brain to ischemia is now recognized to be far more complex than supply/demand events. More important, other than a few studies examining barbiturates or propofol in cardiac surgical patients-for which little or no benefit was observed 46 -no human studies have prospectively investigated the presence or absence of neuroprotection from anesthetics. Post hoc analysis of the IHAST database also found no firm evidence of anesthetic neuroprotection during temporary vascular occlusion in aneurysm surgery, although the primary study was not designed to detect such an effect. 47 In contrast, in vivo laboratory studies have irrefutably shown that anesthetics increase the tolerance of brain to ischemia. This is independent of the type of ischemia (global vs. focal). The mechanisms are likely related to inhibition of glutamatergic (excitatory) neurotransmission and potentiation of GABAergic (inhibitory) neurotransmission, and perhaps intracellular calcium regulation. Many anesthetics meet these criteria (i.e., volatile agents, propofol, barbiturates). Other compounds such as nitrous oxide and opioids seem to be inert. It is clear that animals sustaining stroke while awake have larger resultant lesions than when anesthetized during the insult. 48 But which anesthetic is superior to another remains controversial. Many clinicians have persisted in using thiopental as a first-line agent, although propofol has been substituted in recent years as thiopental has become unavailable. It is difficult, therefore, to recommend one agent as being superior to the others. An exception to this conclusion is etomidate. Although outcome evidence is not available, human studies have provided reasonable physiological evidence that etomidate may exacerbate injury. 49 Another problem is that if one selects an anesthetic to provide intraoperative neuroprotection, the maximally efficacious dose remains undefined. There is surprisingly little laboratory data to guide this discussion. Most outcome studies were designed to compare different drugs at ''equianesthetic doses'' without completion of dose/ response curves for the individual anesthetics. Many would say that maximal effect is obtained coincident with the dose required to provide EEG burst suppression. This is an anachronistic practice based on theoretical information. Repeated studies in rodents indicate that substantially lower doses of anesthetics provide a similar magnitude of protection. 50 As a result of incomplete science regarding anesthetic efficacy in human beings, and in the absence of any other drugs approved for the purpose of neuroprotection in human patients, the anesthesiologist is left with ''providing'' pharmacological neuroprotection based on informed speculation. Perhaps the best we can do for the patient with certainty is to provide oxygenated blood at a sufficient perfusion pressure with simultaneous control of temperature and glucose concentration. In addition, moderate doses of anesthetics (other than etomidate) may be beneficial (Supplemental Digital Content 5, http://links. lww.com/ASA/A266).
EMERGENCY PROCEDURES
It is important to know if the patient is dying of intracranial hypertension. This is particularly true of expanding hematomas. These cases are unquestionable emergencies. The cure is surgical, and the most important contribution the anesthesiologist can make is to allow incision to occur as rapidly as possible. In these patients, effort should be made to minimize increases in ICP (Supplemental Digital Content 6, http://links.lww.com/ASA/A268). Patients who are herniating, or soon to herniate, are not likely to be conscious and prevention of recall is of minimal concern. The anesthesiologist should secure the airway as rapidly as possible and turn the patient over to the surgeon. Small doses of propofol (so as not to cause hypotension, but to decrease metabolic rate and blood volume) or opioid may be appropriate until surgical decompression is achieved, as long as perfusion pressure can be maintained. Inhalational anesthetics and nitrous oxide have no role in the early stage of these procedures. The anesthesia team can secure arterial and additional venous access during preparation of the surgical field. Remember to promote venous drainage with a slight head-up position. Emergency bring-back for postoperative hematoma evacuation is one circumstance where nitrous oxide should be assiduously avoided. Although nitrous oxide has been shown not to alter ICP during routine craniotomy closure, 29 most patients have pneumocephalus in the postoperative period (potentially extending several weeks postoperatively). 51 In the presence of an expanding hematoma, the use of nitrous oxide risks exacerbating intracranial hypertension by expanding pneumocephalus, also likely to be present.
CONCLUSIONS
Anesthesia for craniotomy presents unique concerns. It is rewarding to provide optimal surgical conditions that allow the highest probability of effective surgical intervention. Interactions between the anesthesiologist and surgeon can optimize preparation of the patient, intraoperative management, and planning for recovery. Although management of brain bulk is essential, it also is important to optimize the patient's overall physiological state. This requires stable ventilation and hemodynamic status, also important to patient overall well-being. Nuances in drug selection and specialized physiological management have not been proven to alter patient outcome. Integrating knowledge of the lesion, surgical procedure, and implications for anesthetic care increases the likelihood of an optimal perioperative course.
